Model Releases
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll buil…
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences res
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/
Related
- We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale. It brings GPT-…
- We're expanding access to GPT-Rosalind for academic research. The new Rosalind Academic Plan helps scientific labs bring AI into the work of…
- Our Life Sciences model series is available as a research preview starting today for qualified customers including @Amgen, @moderna_tx, the …
Source: OpenAI (X) | 2026-10-20